2023-2024年南加州大型整合医疗系统中60岁及以上成人呼吸道合胞病毒疫苗接种率
研究纳入2023年9月23日至2024年4月9日Kaiser Permanente南加州60岁及以上患者共1,003,132人,总体RSV疫苗接种率为7.6%。多变量稳健泊松回归显示,70-79.9岁和≥80岁者较60-69.9岁者更可能接种,亚裔、西班牙裔、非西班牙裔黑人、太平洋岛民及美洲原住民或阿拉斯加原住民较非西班牙裔白人更不可能接种,社区剥夺程度较高四分位组较最低四分位组更不可能接种。
要点
- 2023-2024季Kaiser Permanente南加州60岁及以上患者RSV疫苗接种率为7.6%。
- 70-79.9岁(aRR 1.36)和≥80岁(aRR 1.35)较60-69.9岁更可能接种。
- 西班牙裔(aRR 0.52)、非西班牙裔黑人(aRR 0.69)等较非西班牙裔白人更不可能接种。
核心结论
- 研究发现RSV疫苗接种率低,并识别出可能加剧特定人群RSV感染和重症RSV疾病现有差异的接种差异。
- CDC的ACIP近期更新了推荐所有75岁及以上成人接种,这可能开始解决这些差异。
研究设计与样本
- 研究队列纳入2023年9月23日(RSV疫苗在Kaiser Permanente南加州首次可接种日期;N=1,003,132)至2024年4月9日(当地RSV季节结束)所有60岁及以上患者。
- 使用多变量稳健泊松回归估计调整相对风险(aRR)和95%CI,以识别与RSV疫苗接种相关的社会人口学和临床特征。
主要发现
- 总体7.6%的患者接种了RSV疫苗。
- 与60-69.9岁者相比,70-79.9岁者(aRR 1.36;95%CI 1.34-1.39)和≥80岁者(aRR 1.35;95%CI 1.32-1.38)更可能接种。
- 与非西班牙裔白人相比,亚裔(aRR 0.95;95%CI 0.93-0.97)、西班牙裔(aRR 0.52;95%CI 0.51-0.54)、非西班牙裔黑人(aRR 0.69;95%CI 0.67-0.71)、太平洋岛民(aRR 0.91;95%CI 0.84-0.98)及美洲原住民或阿拉斯加原住民(aRR 0.80;95%CI 0.70-0.92)更不可能接种。
- 与最低剥夺四分位组相比,较高社区剥夺四分位组更不可能接种(Q2:aRR 0.86;95%CI 0.85-0.88;Q3:aRR 0.77;95%CI 0.76-0.79;Q4:aRR 0.67;95%CI 0.65-0.68)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
During the 2023-2024 respiratory syncytial virus (RSV) season, vaccination was recommended for adults ≥60 years based on shared clinical decision-making with their healthcare providers. We examined RSV vaccine uptake and characteristics associated with uptake among age-eligible Kaiser Permanente Southern California (KPSC) patients. Our study cohort included all patients ≥60 years from September 23, 2023 (i.e., date RSV vaccination first became available at KPSC; N = 1,003,132) to April 9, 2024 (i.e., end of local RSV season). To identify sociodemographic and clinical characteristics associated with RSV vaccination, we used multivariable robust Poisson regression to estimate the adjusted relative risk (aRR) and 95 % CI. Overall, 7.6 % of patients were vaccinated for RSV. In multivariable regression analyses, those aged 70-79.9 years (aRR: 1.36; 95 % CI: 1.34-1.39) and aged ≥80 years (aRR: 1.35; 95 % CI: 1.32-1.38) were more likely to be vaccinated, compared with those aged 60-69.9 years. Compared with Non-Hispanic White patients, Asian (aRR: 0.95; 95 % CI: 0.93-0.97), Hispanic (aRR: 0.52; 95 % CI: 0.51-0.54), Non-Hispanic Black (aRR: 0.69; 95 % CI: 0.67-0.71), Pacific Islander (aRR: 0.91; 95 % CI: 0.84-0.98), and Native American or Alaska Native (aRR: 0.80; 95 % CI: 0.70-0.92) patients were less likely to be vaccinated. Those in higher neighborhood deprivation quartiles were less likely to be vaccinated (Q2: aRR: 0.86; 95 % CI: 0.85-0.88; Q3: aRR: 0.77; 95 % CI: 0.76-0.79; and Q4: aRR: 0.67; 95 % CI: 0.65-0.68), compared with those in the lowest deprivation quartile. We found low vaccination uptake and identified disparities in vaccination that might exacerbate existing disparities in RSV infection and severe RSV disease among certain populations. CDC's ACIP recently updated their recommendations for all adults 75+ years, and this might begin to address these disparities.
引用
- Patrick R, Mahale P, Ackerson BK, et al. Respiratory syncytial virus vaccine uptake among adults aged ≥60 years in a large, integrated healthcare system in Southern California 2023-2024. Vaccine. 2025. PMID: 40179438. doi:10.1016/j.vaccine.2025.127033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。